Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine for Methamphetamine Dependence
NCT02034201Phase 1Completed
- Sponsor
- University of Arkansas
- Start
- Feb 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Lisdexamfetamine with Placebo (2 arms). Primary endpoint: Percentage of participants that relapse to methamphetamine use at 9 weeks. Started Feb 2014; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT02034201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034201.